Live Status Check

NCT04900818 Recruiting Status

Real-time enrollment status for this solid tumor clinical trial

Current Status

Recruiting

Auto-verified from ClinicalTrials.gov

Checked: July 13, 2026 at 6:28 AM UTC

NCT04900818 Status Summary

NCT NumberNCT04900818
Recruiting StatusRecruiting
ConditionSolid Tumor
PhaseClinical Trial
Target Enrollment330 participants
Active Locations11 sites in the US
SponsorI-Mab Biopharma US Limited
Last Updated on CT.govMarch 5, 2026 (Mar 5, 2026)

About NCT04900818 Enrollment Status

As of July 13, 2026: Clinical trial NCT04900818 is currently recruiting participants. This clinical trial study for solid tumor is actively seeking new participants at 11 locations across the United States. The study is sponsored by I-Mab Biopharma US Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.

Frequently Asked Questions About NCT04900818

Is NCT04900818 still recruiting?

Yes, NCT04900818 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.

Where is NCT04900818 recruiting?

This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.

How do I enroll in NCT04900818?

Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.

When was NCT04900818 status last updated?

The official ClinicalTrials.gov record for NCT04900818 was last updated Mar 5, 2026 (March 5, 2026). HelloStudys verifies this status automatically.

Ready to Apply?

Check your eligibility for this clinical trial